カテゴリー： QYResearch, 世界

世界のプロタンパク転換酵素スブチリシン/ケキシン9型市場

◆英語タイトル：Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Professional Survey Report 2019
◆商品コード：DATA909X13805
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：115
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、プロタンパク転換酵素スブチリシン/ケキシン9型の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、SX-PCK9、O-304、K-312、BLSM-201、DCRPCSK-9、その他に、用途別には、心血管疾患、同種家族性高コレステロール血症、肝疾患、メタボリックシンドローム、その他にセグメント区分し、プロタンパク転換酵素スブチリシン/ケキシン9型の世界市場を分析しました。

・エグゼクティブ・サマリー
・プロタンパク転換酵素スブチリシン/ケキシン9型の世界市場概要
・プロタンパク転換酵素スブチリシン/ケキシン9型の製造コスト構成分析
・プロタンパク転換酵素スブチリシン/ケキシン9型の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・プロタンパク転換酵素スブチリシン/ケキシン9型の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・プロタンパク転換酵素スブチリシン/ケキシン9型のセグメント分析（種類別）
（SX-PCK9、O-304、K-312、BLSM-201、DCRPCSK-9、その他）
・プロタンパク転換酵素スブチリシン/ケキシン9型のセグメント分析（用途別）
（心血管疾患、同種家族性高コレステロール血症、肝疾患、メタボリックシンドローム、その他）
・プロタンパク転換酵素スブチリシン/ケキシン9型の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AFFiRiS AG、Betagenon AB、Bioleaders Corp、BioLingus AG、Catabasis Pharmaceuticals Inc、Dicerna Pharmaceuticals Inc、Eli Lilly and Co、Ensemble Therapeutics Corp、Kowa Co Ltd、Novartis AG、Pfizer Inc、Regeneron Pharmaceuticals Inc、Serometrix LLC、Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd、The Medicines Company、）
・プロタンパク転換酵素スブチリシン/ケキシン9型の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Proprotein Convertase Subtilisin/Kexin Type 9 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Proprotein Convertase Subtilisin/Kexin Type 9 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Proprotein Convertase Subtilisin/Kexin Type 9 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Proprotein Convertase Subtilisin/Kexin Type 9 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Proprotein Convertase Subtilisin/Kexin Type 9 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AFFiRiS AG
Betagenon AB
Bioleaders Corp
BioLingus AG
Catabasis Pharmaceuticals Inc
Dicerna Pharmaceuticals Inc
Eli Lilly and Co
Ensemble Therapeutics Corp
Kowa Co Ltd
Novartis AG
Pfizer Inc
Regeneron Pharmaceuticals Inc
Serometrix LLC
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
The Medicines Company

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
SX-PCK9
O-304
K-312
BLSM-201
DCRPCSK-9
Others

Segment by Application
Cardiovascular Disease
Homozugous Familial Hyperchalesterolemia
Liver Disease
Metabolic Syndrome
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Proprotein Convertase Subtilisin/Kexin Type 9
1.1 Definition of Proprotein Convertase Subtilisin/Kexin Type 9
1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Type
1.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Comparison by Types (2014-2025)
1.2.2 SX-PCK9
1.2.3 O-304
1.2.4 K-312
1.2.5 BLSM-201
1.2.6 DCRPCSK-9
1.2.7 Others
1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Applications
1.3.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Comparison by Applications (2014-2025)
1.3.2 Cardiovascular Disease
1.3.3 Homozugous Familial Hyperchalesterolemia
1.3.4 Liver Disease
1.3.5 Metabolic Syndrome
1.3.6 Others
1.4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Overall Market
1.4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (2014-2025)
1.4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production (2014-2025)
1.4.3 North America Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
1.4.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
1.4.5 China Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
1.4.6 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
1.4.7 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)
1.4.8 India Proprotein Convertase Subtilisin/Kexin Type 9 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
2.3 Manufacturing Process Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
2.4 Industry Chain Structure of Proprotein Convertase Subtilisin/Kexin Type 9

3 Development and Manufacturing Plants Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
3.1 Capacity and Commercial Production Date
3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Proprotein Convertase Subtilisin/Kexin Type 9
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Proprotein Convertase Subtilisin/Kexin Type 9 Production and Capacity Analysis
4.2 Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Analysis
4.3 Proprotein Convertase Subtilisin/Kexin Type 9 Price Analysis
4.4 Market Concentration Degree

5 Proprotein Convertase Subtilisin/Kexin Type 9 Regional Market Analysis
5.1 Proprotein Convertase Subtilisin/Kexin Type 9 Production by Regions
5.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production by Regions
5.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Regions
5.2 Proprotein Convertase Subtilisin/Kexin Type 9 Consumption by Regions
5.3 North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
5.3.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Production
5.3.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
5.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
5.4.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production
5.4.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
5.5 China Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
5.5.1 China Proprotein Convertase Subtilisin/Kexin Type 9 Production
5.5.2 China Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
5.6 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
5.6.1 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production
5.6.2 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
5.7 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
5.7.1 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Production
5.7.2 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export
5.8 India Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis
5.8.1 India Proprotein Convertase Subtilisin/Kexin Type 9 Production
5.8.2 India Proprotein Convertase Subtilisin/Kexin Type 9 Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Proprotein Convertase Subtilisin/Kexin Type 9 Import and Export

6 Proprotein Convertase Subtilisin/Kexin Type 9 Segment Market Analysis (by Type)
6.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production by Type
6.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Type
6.3 Proprotein Convertase Subtilisin/Kexin Type 9 Price by Type

7 Proprotein Convertase Subtilisin/Kexin Type 9 Segment Market Analysis (by Application)
7.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption by Application
7.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Market Share by Application (2014-2019)

8 Proprotein Convertase Subtilisin/Kexin Type 9 Major Manufacturers Analysis
8.1 AFFiRiS AG
8.1.1 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.1.2 AFFiRiS AG Product Introduction, Application and Specification
8.1.3 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Betagenon AB
8.2.1 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.2.2 Betagenon AB Product Introduction, Application and Specification
8.2.3 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bioleaders Corp
8.3.1 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.3.2 Bioleaders Corp Product Introduction, Application and Specification
8.3.3 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 BioLingus AG
8.4.1 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.4.2 BioLingus AG Product Introduction, Application and Specification
8.4.3 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Catabasis Pharmaceuticals Inc
8.5.1 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.5.2 Catabasis Pharmaceuticals Inc Product Introduction, Application and Specification
8.5.3 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Dicerna Pharmaceuticals Inc
8.6.1 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.6.2 Dicerna Pharmaceuticals Inc Product Introduction, Application and Specification
8.6.3 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Eli Lilly and Co
8.7.1 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.7.2 Eli Lilly and Co Product Introduction, Application and Specification
8.7.3 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Ensemble Therapeutics Corp
8.8.1 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.8.2 Ensemble Therapeutics Corp Product Introduction, Application and Specification
8.8.3 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Kowa Co Ltd
8.9.1 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.9.2 Kowa Co Ltd Product Introduction, Application and Specification
8.9.3 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Novartis AG
8.10.1 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
8.10.2 Novartis AG Product Introduction, Application and Specification
8.10.3 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Pfizer Inc
8.12 Regeneron Pharmaceuticals Inc
8.13 Serometrix LLC
8.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
8.15 The Medicines Company

9 Development Trend of Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Market
9.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Trend Analysis
9.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Volume and Value) Forecast 2019-2025
9.2 Proprotein Convertase Subtilisin/Kexin Type 9 Regional Market Trend
9.2.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
9.2.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
9.2.3 China Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
9.2.4 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
9.2.5 Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
9.2.6 India Proprotein Convertase Subtilisin/Kexin Type 9 Forecast 2019-2025
9.3 Proprotein Convertase Subtilisin/Kexin Type 9 Market Trend (Product Type)
9.4 Proprotein Convertase Subtilisin/Kexin Type 9 Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Proprotein Convertase Subtilisin/Kexin Type 9 Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Proprotein Convertase Subtilisin/Kexin Type 9
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share by Types in 2018
Figure SX-PCK9 Product Picture
Figure O-304 Product Picture
Figure K-312 Product Picture
Figure BLSM-201 Product Picture
Figure DCRPCSK-9 Product Picture
Figure Others Product Picture
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Market Share by Applications in 2018
Figure Cardiovascular Disease
Figure Homozugous Familial Hyperchalesterolemia
Figure Liver Disease
Figure Metabolic Syndrome
Figure Others
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (Million USD) (2014-2025)
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs) (2014-2025)
Figure North America Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Million USD) (2014-2025)
Figure Europe Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Million USD) (2014-2025)
Figure China Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Million USD) (2014-2025)
Figure Japan Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Million USD) (2014-2025)
Figure Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Million USD) (2014-2025)
Figure India Proprotein Convertase Subtilisin/Kexin Type 9 Market Size (Million USD) (2014-2025)
Table Proprotein Convertase Subtilisin/Kexin Type 9 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 in 2018
Figure Manufacturing Process Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
Figure Industry Chain Structure of Proprotein Convertase Subtilisin/Kexin Type 9
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Plants Distribution
Table Proprotein Convertase Subtilisin/Kexin Type 9 Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Proprotein Convertase Subtilisin/Kexin Type 9 Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs) of Major Manufacturers (2014-2019)
Table Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share of Major Manufacturers (2014-2019)
Figure Proprotein Convertase Subtilisin/Kexin Type 9 Production Share by Manufacturers in 2018
Table Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share of Major Manufacturers (2014-2019)
Figure Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers in 2018
Table Proprotein Convertase Subtilisin/Kexin Type 9 Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Production by Regions 2014-2019 (K Pcs)
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share by Regions 2014-2019
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share by Regions in 2018
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue by Regions 2014-2019 (Million USD)
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Regions 2014-2019
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Regions in 2018
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption by Regions 2014-2019 (K Pcs)
Table Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Market Share by Regions 2014-2019
Figure North America Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate 2014-2019 (K Pcs)
Figure North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2014-2019 (Million USD)
Table North America Proprotein Convertase Subtilisin/Kexin Type 9 Production, Consumption Import and Export (K Pcs)
Figure Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production, Consumption Import and Export (K Pcs)
Figure China Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate 2014-2019 (K Pcs)
Figure China Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2014-2019 (Million USD)
Table China Proprotein Convertase Subtilisin/Kexin Type 9 Production, Consumption Import and Export (K Pcs)
Figure Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Production, Consumption Import and Export (K Pcs)
Figure India Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate 2014-2019 (K Pcs)
Figure India Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate 2014-2019 (Million USD)
Table India Proprotein Convertase Subtilisin/Kexin Type 9 Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application (2014-2019)
Figure Global Value (Consumption) Proprotein Convertase Subtilisin/Kexin Type 9 Market Share by Application (2014-2019)
Table AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
Table Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
Table Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share (2014-2019)
Figure Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share (2014-2019)
Table Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Main Business and Markets Served
Table Pfizer Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Regeneron Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Serometrix LLC Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Table The Medicines Company Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Proprotein Convertase Subtilisin/Kexin Type 9 Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Proprotein Convertase Subtilisin/Kexin Type 9 by Type (2019-2025)
Table Global Consumption (K Pcs) of Proprotein Convertase Subtilisin/Kexin Type 9 by Application (2019-2025)
Table Proprotein Convertase Subtilisin/Kexin Type 9 Distributors List
Table Proprotein Convertase Subtilisin/Kexin Type 9 Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

AFFiRiS AG、Betagenon AB、Bioleaders Corp、BioLingus AG、Catabasis Pharmaceuticals Inc、Dicerna Pharmaceuticals Inc、Eli Lilly and Co、Ensemble Therapeutics Corp、Kowa Co Ltd、Novartis AG、Pfizer Inc、Regeneron Pharmaceuticals Inc、Serometrix LLC、Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd、The Medicines Company、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のプロタンパク転換酵素スブチリシン/ケキシン9型市場(Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp